LIGHTNING ANTIBODY DISCOVERY
iBody Inc. is a startup company from Nagoya University, Japan.
We will contribute to the improvement of human health and QOL by developing new antibody therapeutics using our unique technology "Ecobody " that can discover natural human antibodies from the human body.
30 Sep 2021
Participation in BioJapan2021
We will participate in BioJapan2021 held in PACIFICO Yokohama from 13th to 15th October 2021.
14 Jul 2021
The Mid-Japan Economist published the article about us.
14 Jun 2021
Patent Registered in US
A patent, about our core technology for antibody protein production in cell-free protein synthesis system or microorganism, has been registered in US. We have exclusive license agreement of this technology globally with Nagoya University.
U.S. Patent Number: 10975376
Title: PROTEIN EXPRESSION METHOD
1 Jun 2021
Adopted for "New Aichi Creative Research and Development Subsidy 2021"
Our project was adopted for "New Aichi Creative Research and Development Subsidy 2021" which Aichi Prefecture supports research and development conducted by companies in fields where future growth is expected, such as next-generation automobiles, aerospace, environment and new energy.
4 Feb 2021
Participation in 2nd Kyoto University Life Science Showcase @ San Diego 2021
We will present at 2nd Kyoto University Life Science Showcase @ San Diego 2021 which is an online showcase event held on March 3.
25 Jan 2021
Selected as a member of J-startup CENTRAL
We were selected as one of twenty companies of “J-Startup CENTRAL” which was organized to support start-up companies aiming for global success by Aichi/Nagoya area, Hamamatsu City and Ministry of Economy, Trade and Industry (METI).